Word

INOSI

Status

Pending

Status Code

686

Status Date

Tuesday, February 13, 2024

Serial Number

79368273

Mark Type

4000

Filing Date

Sunday, March 26, 2023

Published for Opposition

Tuesday, February 13, 2024

Trademark Owner History

Inosi Therapeutics Pty Ltd - Owner At Publication

Classifications

5 Pharmaceutical preparations for use in the treatment of fibrosis, inflammatory and autoimmune disorders, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, pulmonary fibrosis, vascular fibrosis and cardiac fibrosis; pharmaceutical preparations for use in the treatment of systemic sclerosis, Sjogren's syndrome, Rheumatoid arthritis, and systemic lupus erythematosus; pharmaceutical preparations for use in the treatment of cancer and radiation induced lung injury; pharmaceutical preparations for use in the treatment of idiopathic pulmonary fibrosis, and pulmonary arterial hypertension; pharmaceutical preparations for use in the treatment of nonalcoholic steatohepatitis (NASH), fatty liver diseases and disorders and steatohepatitis and other related diseases and disorders

Trademark Events

Feb 14, 2024

Notification Processed By Ib

Feb 13, 2024

Published For Opposition

Jan 24, 2024

Notification Of Possible Opposition Sent To Ib

Jan 24, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jan 24, 2024

Notice Of Publication

Jan 8, 2024

Approved For Pub - Principal Register

Dec 20, 2023

Assigned To Examiner

May 13, 2023

Application Filing Receipt Mailed

May 9, 2023

New Application Office Supplied Data Entered

May 4, 2023

Limitation From Original Application Entered

Apr 27, 2023

Sn Assigned For Sect 66a Appl From Ib